CymaBay Therapeutics
CBAY
#3600
Rank
A$5.42 B
Marketcap
A$47.28
Share price
0.00%
Change (1 day)
213.45%
Change (1 year)

CymaBay Therapeutics (CBAY) Fails to deliver data

Key failure to deliver metrics for CymaBay Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CymaBay Therapeutics (CBAY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CymaBay Therapeutics (CBAY) - since 2014

Volume in USD (price x number of shares), data since 2014

CymaBay Therapeutics (CBAY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$17.53 M37.55%
2023A$12.75 M682.01%
2022A$1.63 M-43.37%
2021A$2.87 M-80.81%
2020A$15 M1707.76%
2019A$0.82 M-82.75%
2018A$4.81 M170.66%
2017A$1.77 M118.41%
2016A$0.81 M-79.51%
2015A$3.97 M-91.13%
2014A$44.75 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
A$45.54 MA$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$42.45 MA$72.09 M๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.82 MA$1.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$13.77 MA$18.36 M๐Ÿ‡บ๐Ÿ‡ธ USA